Altimmune, Inc.
ALTCIK 0001326190 · Pharmaceutical Preparations · Nasdaq
- PHARMATHENE, INC (until 2017-05-03)
- HEALTHCARE ACQUISITION CORP (until 2007-10-15)
Revenue (TTM)
$200K
−46.1% YoY
Q1 May 2026
Net Income (TTM)
−$83.3M
+7.3% YoY
Q1 May 2026
EPS Diluted (TTM)
−$0.92
+25.4% YoY
Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
-44,920.0%
Q1 May 2026
Net Margin
-41,649.0%
Q1 May 2026
Free Cash Flow (TTM)
−$77.84M
Q1 May 2026
Cash
$97.6M
Q1 May 2026
Total Debt
$35.6M
Q1 May 2026
Shares Outstanding
194.47M sh
Q1 May 2026